Posted in | News | Nanobusiness

German Future Award Namination for Nanion's Planar Patch Clamp Technology

The planar patch clamp technology used in a family of automated electrophysiology products developed and marketed by Nanion Technologies GmbH in Munich , Germany , is among four technological and scientific innovations that have been nominated for this year's Deutscher Zukunftspreis (German Future Award).

The nomination of the project "Small Holes – Big Effects: Cell Physiology in a Chip Format" represented by Nanion's CEO, Niels Fertig as well as CSO Andrea Brüggemann and Chairman of the Board Jan C. Behrends (University of Freiburg) was today announced in a press conference by Dr. Gert Haller, Secretary of State in the Office of the Federal President in Berlin. With the Deutscher Zukunftspreis, awarded once a year, the German Federal President honours outstanding achievements in Science and Technology. In their nominations for Germany's most prestigious research award along with the Leibniz Prize, the Jury also appraises the commercial and employment-creation potential of scientific innovations. The prize will be bestowed on one of the four nominated teams by Federal President Horst Köhler on December 6.

Nanion Technologies is a start-up company founded in 2002 by a team of researchers (Dr. Niels Fertig, Dr. Robert H. Blick and Dr. Jan C. Behrends) from the Center for Nanoscience of the University of Munich and the company is run by the management team consisting of Dr. Niels Fertig (CEO), Dr. Andrea Brüggemann (CSO) and Michael George (CTO). Nanion has developed and successfully marketed the Port-a-Patch, a miniaturized patch clamp device, and, since 2006, the Patchliner, a fully automated higher throughput patch-clamp robot. Both devices use the NPC- patch clamp chips which are based on the research which has now been nominated for the award. They replace the traditional glass pipette used in the technique of patch clamping (E. Neher, B. Sakmann, Nobel Prize 1991) and enable automated and higher-throughput testing of potentially ion-channel active substances.

15th October 2007

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Nanion Technologies GmbH. (2019, February 15). German Future Award Namination for Nanion's Planar Patch Clamp Technology. AZoNano. Retrieved on March 03, 2024 from https://www.azonano.com/news.aspx?newsID=5106.

  • MLA

    Nanion Technologies GmbH. "German Future Award Namination for Nanion's Planar Patch Clamp Technology". AZoNano. 03 March 2024. <https://www.azonano.com/news.aspx?newsID=5106>.

  • Chicago

    Nanion Technologies GmbH. "German Future Award Namination for Nanion's Planar Patch Clamp Technology". AZoNano. https://www.azonano.com/news.aspx?newsID=5106. (accessed March 03, 2024).

  • Harvard

    Nanion Technologies GmbH. 2019. German Future Award Namination for Nanion's Planar Patch Clamp Technology. AZoNano, viewed 03 March 2024, https://www.azonano.com/news.aspx?newsID=5106.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit
Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.